NEUROG3 variants and type 2 diabetes in Italians

Minerva Medica

Volumn 97, Issue 5, 2006, Pages 373-378

  Milord, E ^a   Gragnoli, C ^b,c,d  

^a MILLENNIUM PHARMACEUTICALS INC   (United States)

^b Laboratory of Molecular Biology Bios Biotech Fondazione di Ricerca   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d NONE   (Italy)

Author keywords

Allele; Diabetes mellitus type 2; Genotype; Haplotype; Linkage; Linkage disequilibrium; Neurogenin 3

Indexed keywords

5' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FAMILY; FRAMESHIFT MUTATION; GENE; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; NEUROGENIN 3 GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; SINGLE NUCLEOTIDE POLYMORPHISM;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ITALY; LINKAGE (GENETICS); LINKAGE DISEQUILIBRIUM; LOD SCORE; MUTATION; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33846539155     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Mitchell SM, Frayling TM. The role of transcription factors in maturity-onset diabetes of the young. Mol Genet Metab 2002;77:35-43.
2. Gradwohl G, Dierich A, LeMeur M, Guillemot F. Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci U S A 2000;97:1607-11.
3. Jensen J, Heller RS, Funder-Nielsen T, Pedersen EE, Lindsell C, Weinmaster G et al. Independent development of pancreatic alpha- and beta-cells from neurogenin3-expressing precursors: a role for the notch pathway in repression of premature differentiation. Diabetes 2000;49:163-76.
4. Gu G, Dubauskaite J, Melton DA. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 2002;129:2447-57.
5. Jackson AE, Cassell PG, North BV, Vijayaraghavan S, Gelding SV, Ramachandran A et al. Polymorphic variations in the neurogenic differentiation-1, neurogenin-3, and hepatocyte nuclear factor-1alpha genes contribute to glucose intolerance in a South Indian population. Diabetes 2004;53:2122-5.
6. Jensen JN, Hansen L, Ekstrom CT, Pociot F, Nerup J, Hansen T et al. Polymorphisms in the neurogenin 3 gene (NEUROG) and their relation to altered insulin secretion and diabetes in the Danish Caucasian population. Diabetologia 2001;44:123-6.
7. Okada T, Tobe K, Hara K, Yasuda K, Kawaguchi Y, Ikegami H et al. Variants of neurogenin 3 gene are not associated with Type II diabetes in Japanese subjects. Diabetologia 2001;44:241-4.
8. Kim SH, Warram JH, Krolewski AS, Doria A. Mutation screening of the neurogenin-3 gene in autosomal dominant diabetes. J Clin Endocrinol Metab 2001;86:2320-2.
9. del Bosque-Plata L, Lin J, Horikawa Y, Schwarz PE, Cox NJ, Iwasaki N et al. Mutations in the coding region of the neurogenin 3 gene (NEUROG3) are not a common cause of maturity-onset diabetes of the young in Japanese subjects. Diabetes 2001;50:694-6.
10. Gragnoli C, Milord E, Cox N. Worldwide metanalysis of NEUROG3 variants in type 2 diabetes. Obes Metab 2006;2:68-71.
11. Duggirala R, Blangero J, Almasy L, Dyer TD, Williams KL, Leach RJ et al. Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. Am J Hum Genet 1999;64:1127-40.
12. Ghosh S, Watanabe RM, Valle TT, Hauser ER, Magnuson VL, Langefeld CD et al. The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes. Am J Hum Genet 2000;67:1174-85.
13. Wiltshire S, Hattersley AT, Hitman GA, Walker M, Levy JC, Sampson M et al. A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet 2001;69:553-69.
14. Meigs JB, Panhuysen CI, Myers RH, Wilson PW, Cupples LA. A genome-wide scan for loci linked to plasma levels of glucose and HbA(1c) in a community-based sample of Caucasian pedigrees: The Framingham Offspring Study. Diabetes 2002;51:833-40.
15. Gragnoli C, Cockburn BN, Chiaramonte F, Gorini A, Marietti G, Marozzi G et al. Early-onset Type II diabetes mellitus in Italian families due to mutations in the genes encoding hepatic nuclear factor 1 alpha and glucokinase. Diabetologia 2001;44:1326-9.
16. Gragnoli C, Lindner T, Cockburn BN, Kaisaki PJ, Gragnoli F, Marozzi G et al. Maturity-onset diabetes of the young due to a mutation in the hepatocyte nuclear factor-4 alpha binding site in the promoter of the hepatocyte nuclear factor-1 alpha gene. Diabetes 1997;46:1648-51.
17. Gragnoli C, Stanojevic V, Gorini A, Von Preussenthal GM, Thomas MK, Habener JF. IPF-1/MODY4 gene missense mutation in an Italian family with type 2 and gestational diabetes. Metabolism 2005;54:983-8.
18. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002;30:97-101.
19. Lee JC, Smith SB, Watada H, Lin J, Scheel D, Wang J et al. Regulation of the pancreatic pro-endocrine gene neurogenin3. Diabetes 2001;50:928-36.
20. Zhao JH, Curtis D, Sham PC. Model-free analysis and permutation tests for allelic associations. Hum Hered 2000;50:133-9.
21. Abecasis GR, Cookson WO. GOLD-graphical overview of linkage disequilibrium. Bioinformatics 2000;16:182-3.
22. Fingerlin TE, Boehnke M, Abecasis GR. Increasing the power and efficiency of disease-marker case-control association studies through use of allele-sharing information. Am J Hum Genet 2004;74:432-43.